PLSE
Pulse Biosciences Inc
NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$21.17
+4.75% today
Updated 2026-04-30
Market cap
$1.48B
P/E ratio
—
P/S ratio
4,240.58x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$13 – $26
Volume
0.3M
Pulse Biosciences Inc (PLSE) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $68000.00 | $247000.00 | $0.00 | $0.00 | $114000.00 | $1.42M | $700000.00 | $-9000.00 | $0.00 | $350000.00 |
| Revenue growth (YoY) | — | — | — | +263.2% | -100.0% | — | — | +1143.9% | -50.6% | -101.3% | +100.0% | — |
| Cost of revenue | $0.00 | $0.00 | $665000.00 | $665000.00 | $665000.00 | $666000.00 | $1.09M | $1.97M | $11.94M | $1.21M | $1.18M | $1.61M |
| Gross profit | $0.00 | $0.00 | $-665000.00 | $-665000.00 | $-665000.00 | $-666000.00 | $-1.09M | $-550000.00 | $-11.24M | $-1.21M | $-1.18M | $-1.26M |
| Gross margin | — | — | -977.9% | -269.2% | — | — | -960.5% | -38.8% | -1606.3% | 13411.1% | — | -360.0% |
| R&D | $44571.00 | $2.58M | $5.99M | $9.65M | $17.25M | $24.96M | $26.44M | $28.64M | $20.84M | $27.80M | $32.34M | $44.72M |
| SG&A | $73714.00 | $1.22M | $2.93M | $15.50M | $20.05M | $22.33M | $22.86M | $19.07M | $13.96M | $15.78M | $23.92M | $32.03M |
| Operating income | $-308571.00 | $-4.47M | $-9.59M | $-25.81M | $-37.96M | $-47.95M | $-49.97M | $-63.01M | $-58.06M | $-43.57M | $-56.26M | $-76.94M |
| Operating margin | — | — | -14097.1% | -10451.0% | — | — | -43828.9% | -4443.9% | -8293.9% | 484155.6% | — | -21982.6% |
| EBITDA | $-108000.00 | $-3.75M | $-8.83M | $-24.57M | $-36.65M | $-46.79M | $-48.87M | $-61.87M | $-56.70M | $-42.37M | $-55.08M | $-71.71M |
| EBITDA margin | — | — | -12980.9% | -9945.7% | — | — | -42868.4% | -4363.0% | -8100.3% | 470744.4% | — | -20488.6% |
| EBIT | $-308571.00 | $-4.47M | $-9.59M | $-25.57M | $-37.96M | $-47.95M | $-49.97M | $-63.01M | $-58.06M | $-43.57M | $-56.26M | $-72.78M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $646000.00 | $448000.00 | $1.10M | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-474857.00 | $-2.81M | $-9.52M | $-25.57M | $-37.55M | $-45.99M | $-49.74M | $-63.16M | $-58.95M | $-42.21M | $-53.59M | $-72.78M |
| Net income growth (YoY) | — | -492.0% | -238.6% | -168.6% | -46.8% | -22.5% | -8.2% | -27.0% | +6.7% | +28.4% | -26.9% | -35.8% |
| Profit margin | — | — | -13997.1% | -10351.0% | — | — | -43628.9% | -4454.2% | -8421.9% | 469000.0% | — | -20794.6% |